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Abstract
Background: Nowadays, PRRS has become one of the most economically important infectious diseases of pig
worldwide. To better characterize and understand the molecular basis of PRRSV virulence determinants, it would
be important to develop the infectious cDNA clones. In this regard, HuN4-F112, a live-attenuated North-American-
type PRRSV vaccine strain, could serve as an excellent model.
Results: In the study, genomic sequence of HuN4-F112, an attenuated vaccine virus derived from the highly
pathogenic porcine reproductive and respiratory syndrome virus (PRRSV) HuN4 strain, was determined and its full-
length cDNA was cloned. Capped RNA was transcribed in vitro from the cDNA clone and transfected into BHK-21
cells. The supernatant from transfected monolayers were serially passaged in Marc-145 cells. The rescued virus
exhibited a similar growth pattern to its parental virus in Marc-145 cells with peak titers at 48 h post-infection.
Conclusion: In conclusion, we rescued virus from an infectious cDNA clone of attenuated vaccine. It is possible in
the future that a new attenuated PRRSV vaccine with broader specificity and good immunogenicity can be
designed in vitro via an infectious cDNA clone platform coupled with validated information on virulence
determinants.
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Background
P o r c i n er e p r o d u c t i v ea n dr e s p i r a t o r ys y n d r o m e( P R R S )
was first reported in late 1980s in North America and
shortly thereafter in Europe. The disease is characterized
by reproductive failure in late gestation in sows and
respiratory symptoms in pigs of all ages [1-3]. Nowadays,
PRRS has become one of the most economically impor-
tant infectious diseases of pig worldwide [4,5]. The PRRS
virus (PRRSV) is a small enveloped positive-strand RNA
virus belonging to the family Arteriviridae in the order
Nidovirales together with equine arteritis virus (EAV),
simian hemorrhagic fever virus, and lactate dehydrogen-
ase-elevating virus (LDV) of mice[6,7]. PRRSV is further
classified into two distinct genotypes, the North Ameri-
can type and the European type [8,9].
Since May 2006, an atypical PRRS (also known as por-
cine high fever syndrome) has been pandemic in China.
Several studies have confirmed that the causative agent of
the outbreaks was highly pathogenic PRRSV (HP-PRRSV)
and several HP-PRRSV strains were isolated [10-12]. The
genome sequences of several strains representing PRRSV
have been determined and infectious cDNA clones were
developed [13,14]. However, few of these came from a
strain with attenuated virulence. To better characterize
and understand the molecular basis of PRRSV virulence
determinants, it would be important to develop infectious
clone of a virulence-attenuated strain. In this regard,
HuN4-F112, a live-attenuated North-American-type
PRRSV vaccine strain, could serve as an excellent model.
The present article describes the genomic sequence of
a virulence-attenuated PRRSV strain HuN4-F112 and
the successful rescuing of the virus from its infectious
full-length cDNA clone.
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Virus strain and cell line
HuN4-F112 is a virulence-attenuated North-American-
type PRRSV strain derived via consecutive passage in
Marc-145 cells. This virus strain was maintained in our
laboratory as a live-attenuated vaccine [15]. BHK-21 cells
were used to rescue virus by transfection with in vitro-
transcribed RNA. Marc-145 cells were used for virus res-
cue and subsequent experiments. Cells were maintained
as previously described [10].
RNA extraction and molecular cloning of viral genomic
cDNA fragments
Total RNAs were isolated from the supernatants of
MARC-145 cells culture at 48 h post infection (PI) by
using a QIAamp viral RNA kit (QIAGEN). The cDNA
synthesis was performed with SupersciptIII reverse tran-
scriptase (Invitrogen) and reverse primers of each fragment
(Table 1). The PCR primers in Table 1 were designed
mainly according to the sequence of PRRSV HuN4 strain
with the GeneBank accession number of EF635006[10]. Six
fragments (designated as A, B, C, D, E and F. Figure 1).
spanning the full-length genome, were subsequently gener-
ated by PCR amplification with Platinum
® Taq DNA poly-
merase. Each PCR product was cloned into pCR-Blunt
II-TOPO vector (Invitrogen). Nucleotide sequencing of the
clones was performed by Shanghai Auke Inc. (Shanhai,
China) using an ABI 377 automatic sequencer. The
sequence data were analyzed using the Lasergene Software
Package (DNAstar Inc., USA).
Construction of full-length cDNA clone of HuN4-F112
The strategy for construction of full-length cDNA clone of
HuN4-F112 is illustrated in Figure 1. A total of six frag-
ments, covering the complete HuN4-F112 genome, were
subsequently PCR amplified with Platinum
® pfx DNA
polymerase according to the manufacturer’s protocol. The
A at position 14680 was mutated to G by PCR to create a
restriction enzyme site MluI, a translationally silent substi-
tution, both for fragment E and F ligation and as a genetic
marker to differentiate the cloned virus and the parental
virus. The bacteriophage SP6 RNA polymerase promoter
(underlined sequence) and two non-viral guanosine resi-
dues were engineered into primer F16 (Table 1.).
The vector, pBluescript II SK(+) (Stratagene) was
modified, the T7 RNA promoter in the vector was chan-
ged into the SP6 RNA promoter by PCR mutagenesis.
The fragment between the XhoIa n dNotIs i t e sw e r e
replaced by a stuffer fragment, which was prepared as a
synthetic gene containing the restriction enzyme sites as
shown in Figure 1. The PCR-amplified fragments were
gel purified, digested with e n z y m e sa si n d i c a t e di nF i g -
ure 1, and cloned into the modified pBluescript II SK(+)
vector. After each ligation step, the constructed plasmid
was transformed into Escherichia coli DH5a cells and
grown overnight at 37°C in the presence of ampicillin.
Over-lapped cDNA fragments were joined by using
shared restriction sites (Figure 1). Finally, a full-length
HuN4-F112 cDNA clone, pHuN4-F112, was obtained
(Figure 1). The completely assembled full-length cDNA
clone was sequenced.
Table 1 Primers used for amplification of the genome of PRRSV HuN4-F112
Primer
a Sequences
b (5’-3’) Position in HuN4
For fragment A
F16(sp6) CCGCTCGAGTTAATTAAATTTAGGTGACACTATAGGATGACGTATAGGTGTT 1-16
R2355 GTGATGAACCTCGTCACCTTGTGCAGGG 2355-2382
For fragment B
F2300 CTTTGGGCAAGGACTCGGT 2300-2319
R5914 GATCCTGTGTGAACGCCGAC 5914-5933
For fragment C
F5853 CTTCTGCTTCACCGCGTGT 5853-5871
R8825 AAGAAGATTGGCGGCAAAC 8825-8843
For fragment D
F8764 GCAGGTGCCTTGAAGCTGAT 8764-8783
R11910 CTCATGCTGATGGCATTAGC 11910-11929
For fragment E
F11851 AGGACTGGGAGGATTACAAT 11851-11870
R14670 CGGACGACAAACGCGTGGTTAT 14670-14691
For fragment F
F14668 TGATAACCACGCGTTTGTCGTC 14668-14689
R15313 TATAGCGGCCGCATTTAAAT(T)32AATTACGG 15313-15320
a Primer names are organized in groups. Prefixes: F, forward PCR primer; R, reverse PCR primer.
b The SP6 RNA polymerase promoter sequence in primer F16 is shown in italics. Restriction sites introduced by PCR are underlined and specified in parentheses
at the end of the sequence. Silent mutations within the viral sequence are shown in boldface. Fragments A through F correspond to the letters in Fig. 1.
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The full-length cDNA clone was linearized by cleavage
with restriction enzyme SwaI, which cuts downstream of
the poly (A) tail. Linearized plasmid DNA was used for in
vitro transcription of capped RNA with the mMessage
High Yield Capped RNA Transcription kit (Ambion)
according to the manufacturer’s instructions and including
treatment of the RNA with DNase to remove input plas-
mid. The transcribed RNA was purified with a MEGA
clear kit (Ambion) following the manufacturer’si n s t r u c -
tion and quantified by spectrophotomery. The synthetic
RNA was transfected into BHK-21 cells using DMRIE-C
reagent (Invitrogen) according the protocol recommended
by the manufacturer. To rescue the virus, cell culture
supernatant obtained 24 h post-transfection was serially
passaged on MARC-145 cells. Rescue of infectious virus
was confirmed by indirect immunofluorescence assay
(IFA) using anti-N monoclonal antibody N3H2 [16].
Discrimination between the cloned virus and the parental
virus
Viral RNAs were extracted from cell culture superna-
tants of the infected cells by using an RNeasy Plus Mini
kit (QIAGEN). RT-PCR was performed with the pairs of
primer: JD1, 5’-CACAGCTCCACAGAAGGTGC-3’ and
JD2, 5’-TAACAGCTTTTCTGCCACCC-3’. The ampli-
fied product was digested by MluI to check the genetic
marker engineered into the cloned virus.
In vitro stability and growth kinetics of the rescued virus
To assess the replication stability of the rescued viruses,
the cloned viruses were serially passaged (F4 to F6) in
MARC-145 cells, and the CPE and the presence of
genetic markers in the viruses were observed. Virus titers
in cell cultures for each of passage were determined by a
microtitration infectivity assay and recorded as TCID50
per milliliter by using the Reed-Muench method. Briefly,
cells were prepared in 96-well plates and inoculated with
virus suspensions (100 μL/well), which were prepared by
serial 10-fold dilution. After absorption for 1 h at 37°C,
the liquids in the wells were removed, and DMEM with
5% FBS was added to the wells. Plates were incubated for
an additional 72 to 96 h; virus titers were determined by
the presence of a visible CPE.
Growth kinetics studies were performed by infecting
MARC-145 cells with the rescued virus and parental
virus at an MOI of 0.1. After 1 h of virus adsorption, cells
were washed and incubated in DMEM with 3% FBS at
37°C. The virus-infected supernatants were collected at
various time points and viral titers were determined and
expressed as TCID50 per milliliter.
Results
Sequence determination of the PRRSV HuN4-F112
genome
The PRRSV HuN4-F112 strain genome was determined to
be 15352 nucleotides in length. The genome contain nine
deduced open reading frames (ORF) which is flanked by a
5’untranslated region (5’UTR) of 189 nt and a 3’untrans-
lated region (3’UTR) of 150 nt excluding the poly(A) tail,
respectively.
Construction of full-length cDNA clone of HuN4-F112 and
determination of its infectivity
The plasmid pHuN4-F112 that contained the full-length
cDNA of the entire viral genome of the HuN4-F112 was
linearized by digestion with SwaI, and used for in vitro
transcription by SP6 RNA polymerase to synthesize capped
Figure 1 Strategy for the construction of the full-length cDNA clone of an attenuated live PRRSV vaccine strain, HuN4-F112.T h e
organization of the viral genome is shown, as are the positions of the unique restriction sites used for cloning purposes. The numbers 1a, 1b,
2a, 2b and 3 through 7 indicate the PRRSV open reading frames. An SP6 RNA promoter with two nontemplated G residues preceded the viral
genome. The complete viral genome was divided into six fragments flanked by unique restriction sites, represented by the horizontal lines
labeled A through F. The fragments were inserted into the modified pBluescript II SK(+) vector.
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cDNA clone, BHK-21 cells were transfected with the
capped RNA with the transfection reagent DMRIE-C.
Supernatants from the transfected BHK-21 cells obtained
24 h post transfection were serially passaged on Marc-145
cells, at 72 h post-infection (p.i.), cytopathic effects (CPEs)
was observed in cells (Figure 2). Three days following
transfection of MARC-145 cells with supernatants of cells
infected with cloned and parental virus, immunofluores-
cence assay (IFA) was performed to examine the expres-
sion of nucleocapsid (N) protein. As shown in Figure 3, the
N proteins of both cloned and parental virus were
expressed in MARC-145 cells. Thus, our results show that
infectious virus was rescued from BHK-21 and MARC-145
cells transfected with capped in vitro-transcribed RNA.
Discrimination between cloned virus and parental virus
To differentiate the rescued viruses and parental viruses, a
genetic marker, MluI site at nt 14680, was engineered into
the genome length cDNA. As expected, the RT-PCR frag-
ment derived from the cloned virus was cleaved by MluI,
generating two fragments of 360 bp and 92 bp (Figure 4).
In contrast, the PCR amplification products derived from
the parental isolate was not cleaved by MluI (Figure 4).
Characterization of the cloned virus
Growth kinetics studies were performed to compare the
growth of rescued virus and parental virus in MARC-145
cells. Results (Figure 5) show that growth kinetics of res-
cued virus and parental virus was not significantly different
from each other and that titers peaked at 48 h pi for both
viruses. The result indicates that the rescued virus pos-
sesses growth characteristics similar to the parental virus.
Discussion and conclusions
In this study, we described the complete nucleotide
sequence of the viral genome and the construction of
infectious cDNA clone of HuN4-F112, a live-attenuated
Figure 2 Cytopathic effect (CPE) of the cloned virus in Marc-145 cells. Supernatants from the transfected BHK-21 cells obtained 24 h post-
transfection were serially passaged on Marc-145 cells, at 72 h post-infection (p.i.), CPE was observed in rescued virus (A), while mock-infected
cells remained normal (B).
Figure 3 Immunofluorescence assay. MARC-145 cells infected with the 3rd passage culture of the viruses were fixed 48 h post-inoculation and
examined by immunofluoresence assay with the anti-N monoclonal antibody (N3H2) of PRRSV.
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tion of capped in vitro transcripts, derived from this
clone, into BHK-21 cells and Marc-145 cells led to effi-
cient recovery of infectious virus from cultured cells.
Indeed, at 3 days post-transfection, CPE was observed in
transfected cells. The rescued virus displayed similar
growth properties to its parent virus in MARC-145 cells.
Detection of the MluI genetic marker indicates that the
rescued virus remained genetically stable during passage
in cells.
Since May 2006, atypical PRRS (so-called porcine high
fever syndrome (PHFS) in china) was pandemic in china.
Several studies have confirmed that the causative agent
of this outbreak was highly pathogenic PRRSV (HP-
PRRSV), several HP-PRRSV strains were isolated and
their reverse genetic systems were developed by different
labs [13,17-20]. We also isolated an atypical PRRS strain
named HuN4 and attenuated this strain in vitro by passa-
ging on Marc-145 cells, the attenuated strain was desig-
nated HuN4-F112 (112
th passage). Study shows that
HuN4-F112 was sufficiently attenuated and antigenic
enough to confer protection against a lethal wild-type
challenge [10,15].
Sequence alignment between HuN4-F112 and its par-
ental virulent isolate HuN4 showed that both the 5’UTR
and 3’UTR are identical and mutations are presented in
both nonstructural and structural protein regions. We
surmise that the basis of PRRSV attenuation may be mul-
tifactor. A recent study also confirmed this by construct-
ing of a series of chimeric viruses where specific genomic
regions of a highly virulent PRRSV infectious clone
(FL12) were replaced with their counterparts of an atte-
nuated vaccine strain PrimePac. Results indicate that
NSP3-8 and GP5 are the location of major virulence
determinants, while other virulence determinants may
also be contained in NSP1-3, NSP10-12 and GP2 [21].
T h ea v a i l a b i l i t yo ft h ec o m p l e t eg e n o m es e q u e n c ea n d
infectious clone of the virulence-attenuated strain HuN4-
F112 would make it possible to use a comparative virol-
ogy approach to dissect the virulence determinants of
PRRSV. This approach will likely yield new information
on PRRSV virulence regulation and virus-host interaction
in the future.
In conclusion, we rescued virus from an infectious
cDNA clone of attenuated vaccine. It is possible in the
future that a new attenuated PRRSV vaccine with broader
specificity and good immunogenicity can be designed in
vitro via an infectious cDNA clone platform coupled with
validated information on virulence determinants.
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